Our Publications

Our Publications


  1. End of selection criteria based on sexual orientation: An international symposium on alternatives to donation deferral. Lewin A, Goldman M, Busch MP, Davison K, van de Laar T, Tiberghien P, et al.  Vox Sang. 2024. https://pubmed.ncbi.nlm.nih.gov/38270352/
  2. International review of blood donation nucleic acid amplification testing. Faddy HM, Osiowy C, Custer B, Busch M, Stramer SL, Adesina O, et al.  Vox Sang. 2024. https://pubmed.ncbi.nlm.nih.gov/38390819/
  3. The expanding role of blood and tissue establishments in the development of advanced therapy medicinal products. Aisling Horan, Shada Warreth, Tor Hervig, Allison Waters.  Cytotherapy, 2024. https://pubmed.ncbi.nlm.nih.gov/38441513/


  1. Their health is our wealth: lay perceptions on the health impacts of blood donation. Fogarty H, McSweeney E, Hervig T.  Blood Transfus. 2023 Sep 22. doi: 10.2450/BloodTransfus.625. PMID: 37847206.
  2. Changing Strategies for the Detection of Bacteria in Platelet Components in Ireland: From Primary and Secondary Culture (2010–2020) O’Flaherty, N.; Bryce, L.; Nolan, J.; Lambert, M. Microorganisms 202311, 2765. 
  3. The impact of donor biological variation on the quality and function of cold-stored platelets. Lorusso A, Croxon H, Faherty-O'Donnell S, Field S, Fitzpatrick Á, Farrelly A, Hervig T, Waters A. T Vox Sang. 2023 Sep;118(9):730-737
  4. The changing profile of SARS-CoV-2 serology in Irish blood donors. Coyne D, Butler D, Meehan A, Keogh E, Williams P, Carterson A, Hervig T, O'Flaherty N, Waters A. Glob Epidemiol. 2023 Dec;5:100108. Epub 2023 Apr 21. PMID: 37122774
  5. The 'scintilla' starting vaso-occlusion in sickle cell disease. Piccin A, Magzoub I, Hervig T. Br J Haematol. 2023 May;201(3):379-380. Epub 2023 Jan 17. PMID: 36647924.
  6. Training of medical students in the use of emergency whole blood collection and transfusion in the framework of a civilian walking blood. Apelseth TO, Kristoffersen EK, Strandenes G, Hervig T. Transfusion. 2023 Apr 14. PMID: 37057630.
  7. Current transfusion practice and need for new blood products to ensure blood supply for patients with major hemorrhage in Europe. Apelseth TO, Doyle B, Evans R, George C, Humbrecht C, Klei T, Najdovski T, Sigurjónsson ÓE, Wiltshire M, de Korte D. Transfusion. 2023 Apr 14. PMID: 37057621.
  8. Serologic reactivity of unidentified specificity in antenatal testing and hemolytic disease of the fetus and newborn: The BEST collaborative study. Lu W, Ziman A, Yan MTS, Waters A, Virk MS, Tran A, Tang H, Shih AW, Scally E, Raval JS, Pandey S, Pagano MB, Shan H, Moore C, Morrison D, Cormack O, Fitzgerald J, Duncan J, Corean J, Clarke G, Yazer M. Transfusion. 2023 Apr;63(4):817-825. Epub 2023 Feb 23. PMID: 36815517.
  9. Identification of protective and 'at risk' HLA genotypes for the development of pseudotumours around metal-on-metal hip resurfacings.Sheridan GA, Hanlon M, Welch-Phillips A, Spratt K, Hagan R, O'Byrne JM, Kenny PJ, Kurmis AP, Masri BA, Garbuz DS, Hurson CJ. Bone Jt Open. 2023 Mar 14;4(3):182-187. PMID: 37051827.
  10. Motivators and barriers to blood donation among potential donors of African and Caucasian ethnicity.Fogarty H, Sardana M, Sheridan L, Chieng P, Kelly S, Ngwenya N, Sheehan C, Morris K, Tuohy E. Blood Transfus. 2023 Jan;21(1):13-23. Epub 2022 Jun 12. PMID: 35848628.
  11. The impact of donor biological variation on the quality and function of cold-stored platelets Alice LorussoHarry CroxonSarah Faherty-O'DonnellStephen FieldÁine FitzpatrickAileen FarrellyTor HervigAllison Waters.

  12. Carmel Maria MooreAlice LorussoLiam MorganSinead BrazilHarry CroxonAllison WatersAileen FarrellyTor HervigAnna Curley


  1. Human T-lymphotropic virus in Irish blood donors: Impact on future testing strategy. Williams P, O'Flaherty N, Field S, Waters A. Transfusion. 2022 Jul 13.
  2. Survey of blood centre readiness regarding removal of DEHP from blood bag sets: The BEST Collaborative Study. Razatos A, Acker JP, de Korte D, Bégué S, Noorman F, Doyle B, Zia M, Min K; Biomedical Excellence for Safer Transfusion Collaborative. Vox Sang. 2022 Jun;117(6):796-802.
  3. Lessons learnt from syphilis-infected blood donors: a timely reminder of missed opportunities. Harvala H, Reynolds C, Fabiana A, Tossell J, Bulloch G, Brailsford S, Blackmore S, Pomeroy L. Sex Transm Infect. 2022 Jun;98(4):293-297.
  4. Evaluation of platelet concentrates prepared from whole blood donations with collection times between 12 and 15 min: The BEST Collaborative study. de Korte D, Bontekoe IJ, Fitzpatrick Á, Marks D, Wood B, Gravemann U, Bohoněk M, Kutner JM; Biomedical Excellence for Safer Transfusion Collaborative. Vox Sang. 2022 May;117(5):671-677.
  5. Identification of rabbit hepatitis E virus (HEV) and novel HEV clade in Irish blood donors. Baylis SA, O'Flaherty N, Burke L, Hogema B, Corman VM. J Hepatol. 2022 Apr 26:S0168-8278(22)00250-1.
  6. Confirmed circulation of SARS-CoV-2 in Irish blood donors prior to first national notification of infection. Butler D, Coyne D, Pomeroy L, Williams P, Holder P, Carterson A, Field S, Waters A, O'Flaherty N. J Clin Virol. 2022 Jan;146:105045.
  7. The oxygen saturation of red blood cell concentrates: The basis for a novel index of red cell oxidative stress. Yoshida T, McMahon E, Croxon H, Dunham A, Gaccione P, Abbasi B, Beckman N, Omert L, Field S, Waters A. Transfusion. 2022 Jan;62(1):183-193. 


  1. An international comparison of HIV prevalence and incidence in blood donors and general population: a BEST Collaborative study. Germain M, Grégoire Y, Custer BS, Goldman M, Bravo M, Kamel H, Davison K, Field S, van den Hurk K, van de Laar TJW, Irving DO, Jones A, Liumbruno G, Morley S, O'Brien SF, Pillonel J, Steinsvåg CT, Takanashi M, Tsuno NH, Vesga Carasa MA, Wendel S, Vassallo RR, Tiberghien P; BEST Collaborative. Vox Sang. 2021 Nov;116(10):1084-1093.
  2. Maternal morbidity in placenta accreta spectrum following introduction of a multi-disciplinary service compared to standard care: an Irish perspective. Bartels HC, Mulligan KM, Craven S, Rogers AC, Higgins S, O'Brien DJ, McVey R, McParland P, Walsh JM, Carroll S, Corcoran S, Robson M, Mahony R, Downey P, Brophy D, Colleran G, McAuliffe FM, Brennan DJ. Ir J Med Sci. 2021 Nov;190(4):1451-1457.
  3. Establishment of transfusion-relevant bacteria reference strains for red blood cells. Prax M, Spindler-Raffel E, McDonald CP, Bearne J, Satake M, Kozakai M, Rojo J, Hanschmann KO, Lambrecht B, Grundmann U, O'Flaherty N, Klimek A, Bekeredjian-Ding I, Gathof BS, Störmer M, Süßner S, Renke C, Lee CK, Knabbe C, Vollmer T, Keil SD, Shipps ME, Wagner SJ, Jentsch U, Mpumlwana X, Cloutier M, Bringmann P, Lu T, Ramirez-Arcos S, Kou Y, Krut O; ISBT Transfusion-Transmitted Infectious Diseases Working Party, Subgroup on Bacteria. Vox Sang. 2021 Jul;116(6):692-701.
  4. A snapshot of ABO, RH, and JK blood group systems in modern Ireland. Browne A, Kinsella A, Keogh M, Morris K, Field S. Health Sci Rep. 2021 Jun 12;4(2):e292.
  5. Partial compliance with symptom-based testing pathways reveals asymptomatic carriage of SARS-CoV-2 in Ireland. Chan GY, Rajan L, De Gascun C, O'Flaherty N. Ir J Med Sci. 2021 May;190(2):485-489.
  6. Changing trends in corneal transplantation: a national review of current practices in the Republic of Ireland. Iselin KC, Greenan E, Hynes C, Shaw S, Fulcher T, Power WJ, Quill B, Guerin M, Lee WH, Murphy CC. Ir J Med Sci. 2021 May;190(2):825-834.
  7. Major obstetric haemorrhage: Incidence, management and quality of care in Irish maternity units. Greene RA, McKernan J, Manning E, Corcoran P, Byrne B, Cooley S, Daly D, Fallon A, Higgins M, Jones C, Kinsella I, Murphy C, Murphy J, Bhuinneain MN; Maternal Morbidity Advisory Group. Eur J Obstet Gynecol Reprod Biol. 2021 Feb;257:114-120.
  8. Residual red cells in blood components: A multisite study of fully automated enumeration using a hematology analyzer. Cavagnetto C, Alejo Blanco R, McKenna H, Willmott L, Aydogdu E, Akinyemi N, Standring H, Procter S, Lagerberg JW, Johansson E, Croxon H, de Korte D, Garner SF, Shirakami A, Saker J, Linssen J, Cardigan R. Transfusion. 2021 Feb;61(2):568-578. 


  1. Donor oocyte-facilitated reproduction: Time to revisit the BSH antenatal guidelines? Quigley J, Sweetman D, Allen C, Higgins MF, Cantwell C, Doyle B, Downey P, Fitzgerald J. Transfus Med. 2020 Dec;30(6):525-526.
  2. Trends in platelet distributions from 2008 to 2017: a survey of twelve national and regional blood collectors. Yazer MH, Shaz B, Seheult JN, Apelseth TO, de Korte D, Devin G, Devine D, Doncaster C, Field S, Flanagan P, Huet J, Mendrone A Jr, O'Brien C, Pink J, Rashleigh M, Shinar E, Takanashi M, Tian E, Tiberghien P, van den Berg K, Schmitt C. Vox Sang. 2020 Nov;115(8):703-711.
  3. Expresser phenotype determines ABO(H) blood group antigen loading on platelets and von Willebrand factor. O'Donghaile D, Jenkins PV, McGrath RT, Preston L, Field SP, Ward SE, O'Sullivan JM, O'Donnell JS. Sci Rep. 2020 Oct 27;10(1):18366.
  4. Two novel antithetical KN blood group antigens may contribute to more than a quarter of all KN antisera in Europe. Grueger D, Zeretzke A, Habicht CP, Skaik Y, Wagner FF, Scharberg EA, Costelloe A, Martens J, Verboom M, Bugert P, Schneeweiss C. Transfusion. 2020 Oct;60(10):2408-2418. 
  5. Anti-D immunization rates may exceed 50% in many clinically relevant settings, despite varying widely among patient cohorts. Flegel WA, Wagner FF, Ó Donghaile DP. Transfusion. 2020 May;60(5):1109-1110.


  1. International Forum on Occult hepatitis B infection and transfusion safety. Seed CR, Allain JP, Lozano M, Laperche S, Gallian P, Gross S, Kwon SY, Oh EY, Kim JN, Chua SS, Lam S, Ang AL, Tsoi WC, Hewitt PE, Davison KL, Tettmar K, O'Flaherty N, Boland F, Williams P, Pomeroy L, Wendel S, Fachini R, Scuracchio P, Carminato P, Fearon M, O'Brien SF, Delage G, Kiely P, Hoad V, Matsubayashi K, Satake M, Taira R, Stramer SL, Sauleda S, Bes M, Piron M, El Ekiaby M, Vermeulen M, Levičnik Stezinar S, Nograšek P, Jarvis LM, Petrik J, Charlewood R, Flanagan P, Grabarczyk P, Kopacz A, Łętowska M, Seifried E, Schmidt M. Vox Sang. 2019 May;114(4):e1-e35.
  2. Blood Donor Screening for Hepatitis E Virus in the European Union. Boland F, Martinez A, Pomeroy L, O'Flaherty N. Transfus Med Hemother. 2019 Apr;46(2):95-103.
  3. Is platelet gel safe enough for neutropenic patients? Piccin A, Bacigalupo A, Zini G, Hamidieh AA, Bianchi M, Sica S, Valentini CG, Wolf D, Dazzi F, Fontanella F, Krampera M, Field S, Smith OP. Transfus Apher Sci. 2019 Apr;58(2):190-191.


  1. Hepatitis E virus - key points for the clinical haematologist. O'Gorman J, Burke Á, O'Flaherty N. Br J Haematol. 2018 Jun;181(5):579-589.
  2. Transfusion-transmitted hepatitis B virus (HBV) infection from an individual-donation nucleic acid (ID-NAT) non-reactive donor. O'Flaherty N, Ushiro-Lumb I, Pomeroy L, Ijaz S, Boland F, De Gascun C, Fitzgerald J, O'Riordan J. Vox Sang. 2018 Apr;113(3):300-303.
  3. Changes in plasma unit distributions to hospitals over a 10-year period. Seheult JN, Shaz B, Bravo M, Croxon H, Devine D, Doncaster C, Field S, Flanagan P, Germain M, Grégoire Y, Kamel H, Karafin M, Kelting N, Lewis M, O'Brien C, Murphy MF, Rossmann S, Sayers M, Shinar E, Takanashi M, Titlestad K, Yazer MH; Biomedical Excellence for Safer Transfusions (BEST) Collaborative. Transfusion. 2018 Apr;58(4):1012-1020.
  4. Timing of gamma irradiation and blood donor sex influences in vitro characteristics of red blood cells. de Korte D, Thibault L, Handke W, Harm SK, Morrison A, Fitzpatrick A, Marks DC, Yi QL, Acker JP; Biomedical Excellence for Safer Transfusion (BEST) collaborative. Transfusion. 2018 Apr;58(4):917-926.
  5. Vox Sanguinis International Forum on application of fetal blood grouping. Daniels G, Finning K, Lozano M, Hyland CA, Liew YW, Powley T, Castilho L, Bonet Bub C, Kutner JM, Banch Clausen F, Christiansen M, Sulin K, Haimila K, Legler TJ, Lambert M, Ryan H, Ní Loingsigh S, Matteocci A, Pierelli L, Dovc Drnovsek T, Bricl I, Nogués N, Muñiz-Diaz E, Olsson ML, Wikman A, de Haas M, van der Schoot CE, Massey E, Westhoff CM. Vox Sang. 2018 Feb;113(2):e26-e35.


  1. Early hepatitis E infection in an unrelated hematopoietic progenitor stem cell donor. O'Donghaile D, O'Flaherty N, Field S. Bone Marrow Transplant. 2017 Oct;52(10):1471-1472.
  2. HLAMatchmaker is effective for selecting appropriate platelet units for alloimmunised thrombocytopaenic patients who are refractory to random donor platelets. O'Rafferty C, Rooney G, Hagan R, Woolfson M, O'Donghaile D, Fitzgerald J. Transfus Med. 2017 Oct;27 Suppl 5:369-374.

Sign up to Our Newsletter

Sign up to Our Newsletter

loading form...